全文获取类型
收费全文 | 706篇 |
免费 | 84篇 |
国内免费 | 25篇 |
专业分类
815篇 |
出版年
2024年 | 4篇 |
2023年 | 29篇 |
2022年 | 46篇 |
2021年 | 47篇 |
2020年 | 65篇 |
2019年 | 118篇 |
2018年 | 45篇 |
2017年 | 24篇 |
2016年 | 27篇 |
2015年 | 23篇 |
2014年 | 43篇 |
2013年 | 55篇 |
2012年 | 29篇 |
2011年 | 23篇 |
2010年 | 30篇 |
2009年 | 16篇 |
2008年 | 22篇 |
2007年 | 23篇 |
2006年 | 22篇 |
2005年 | 14篇 |
2004年 | 14篇 |
2003年 | 18篇 |
2002年 | 18篇 |
2001年 | 8篇 |
2000年 | 1篇 |
1999年 | 5篇 |
1998年 | 6篇 |
1997年 | 4篇 |
1996年 | 5篇 |
1995年 | 3篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 5篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 3篇 |
排序方式: 共有815条查询结果,搜索用时 15 毫秒
21.
谭春琼 《中国应用生理学杂志》2014,(5):437-438
目的:探讨山药多糖治疗大鼠糖尿病肾病的作用。方法:将sD大鼠40只随机分为4组(n=10):对照组、模型组、苯那普利组和山药多糖组。复制糖尿病肾病大鼠模型,实验第10周统一处死大鼠,测定大鼠肾重/体重、血糖(Bs)、血脂及肾功能。结果:山药多糖能显著降低肾重/体重、血糖(BS)和血脂,改善肾功能。结论:山药多糖具有治疗糖尿病肾病的作用。 相似文献
22.
为观察川陈皮素对糖尿病肾病的治疗作用,本研究选用120只SD大鼠适应性喂养2周后分为正常组(20只)和糖尿病肾病造模组(100只),成功构建糖尿病肾病模型后选取50只,分为模型组,川陈皮素低剂量、中剂量和高剂量组以及阳性药物贝那普利组,每组10只,治疗6周后处死,收集尿液检测24h-尿量和24h-尿蛋白,收集血液检测血糖、胰岛素、血脂、肾功能指标和炎性因子的变化特点,收集肾脏检测肾脏病理学以及肾脏组织中凋亡相关蛋白Bcl-2、Bax、Caspase-3表达水平。结果显示,模型组有明显肾小球增大、部分系膜增生和间质纤维化,相较于模型组,贝那普利组和川陈皮素三个剂量组肾小球病变减轻;与模型组相比,贝那普利组和川陈皮素低、中、高剂量组UCr、24h蛋白尿、BUN、Scr、血糖、TG、TC、IL-1、IL-6和TNF-α明显降低(P<0.05),胰岛素含量明显升高(P<0.05);与模型组相比,贝那普利组和川陈皮素低、中和高剂量组Bax和Caspase-3明显降低(P<0.05),Bcl-2明显升高(P<0.05)。上述研究表明,川陈皮素对糖尿病肾脏损害大鼠肾功能具有明显的保护作用。 相似文献
23.
Diabetic retinopathy (DR) is the prevalent microvascular complication of diabetes mellitus (DM), and it may lead to permanent blindness. The previous publication has indicated that both inflammatory response and oxidative stress are critical factors involved in DR progression, however, the accurate regulatory mechanism remains to be revealed. Src homology region 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2), a member of the protein tyrosine phosphatase family, was reported to play a role in diabetic nephropathy, whereas its function in DR was unknown and required further exploration. The level of phosphorylated, not the total, SHP2 increased in the retinas of rats with streptozotocin injection-induced DM. Further, the intravitreal injection of SHP2 shRNA lentivirus alleviated retinal pathological changes, and inhibited inflammatory response and oxidative stress, which were accompanied with Yes-associated protein 1 (YAP1) deactivation in DR rats. Additional co-immunoprecipitation results confirmed the interaction of SHP2 and YAP1. Collectively, our data preliminarily show that DR amelioration-induced by SHP2 inhibition in rats may attribute to the deactivation of YAP1 pathway. 相似文献
24.
Boquan Wu Shilong You Hao Qian Shaojun Wu Saien Lu Ying Zhang Yingxian Sun Naijin Zhang 《Journal of cellular and molecular medicine》2021,25(14):6470-6478
At present, cardiovascular disease is one of the important factors of human death, and there are many kinds of proteins involved. Sirtuins family proteins are involved in various physiological and pathological activities of the human body. Among them, there are more and more studies on the relationship between sirtuin2 (SIRT2) protein and cardiovascular diseases. SIRT2 can effectively inhibit pathological cardiac hypertrophy. The effect of SIRT2 on ischaemia-reperfusion injury has different effects under different conditions. SIRT2 can reduce the level of reactive oxygen species (ROS), which may help to reduce the severity of diabetic cardiomyopathy. SIRT2 can affect a variety of cardiovascular diseases, energy metabolism and the ageing of cardiomyocytes, thereby affecting heart failure. SIRT2 also plays an important role in vascular disease. For endothelial cell damage used by oxidative stress, the role of SIRT2 is bidirectional, which is related to the degree of oxidative stress stimulation. When the degree of stimulation is small, SIRT2 plays a protective role, and when the degree of stimulation increases to a certain level, SIRT2 plays a negative role. In addition, SIRT2 is also involved in the remodelling of blood vessels and the repair of skin damage. 相似文献
25.
26.
Tian Hu Xin-Yi Lu Jing-Jing Shi Xiao-Qi Liu Qu-Bo Chen Qi Wang Yun-Bo Chen Shi-Jie Zhang 《Journal of cellular and molecular medicine》2020,24(6):3449-3459
Epidemiological studies have found that diabetes and cognitive dysfunction are closely related. Quercetin has been certified with the effect on improving diabetes mellitus (DM) and cognitive impairment. However, the effect and related mechanism of quercetin on diabetic encephalopathy (DE) are still ambiguous. In this study, we used the db/db mice (diabetic model) to discover whether quercetin could improve DE through the Sirtuin1/NLRP3 (NOD-, LRR- and pyrin domain-containing 3) pathway. Behavioural results (Morris water maze and new object recognition tests) showed that quercetin (70 mg/kg) improved the learning and memory. Furthermore, quercetin alleviated insulin resistance and the level of fasting blood glucose. Besides, Western blot analysis also showed that quercetin increased the protein expressions of nerve- and synapse-related protein, including postsynapticdensity 93 (PSD93), postsynapticdensity 95 (PSD95), brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the brain of db/db mice. Quercetin also increased the protein expression of SIRT1 and decreased the expression of NLRP3 inflammation-related proteins, including NLRP3, the adaptor protein ASC and cleaved Caspase-1, the pro-inflammatory cytokines IL-1β and IL-18. In conclusion, the present results indicate that the SIRT1/NLRP3 pathway may be a crucial mechanism for the neuroprotective effect of quercetin against DE. 相似文献
27.
Jierong Luo Dan Yan Sisi Li Shiming Liu Fei Zeng Chi Wai Cheung Hong Liu Michael G. Irwin Huansen Huang Zhengyuan Xia 《Journal of cellular and molecular medicine》2020,24(2):1760-1773
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) following the disassociation with its repressor Keap1 under oxidative stress can maintain inner redox homeostasis and attenuate DCM with concomitant attenuation of autophagy. We postulated that ALP treatment may activate Nrf2 to mitigate autophagy over‐activation and consequently attenuate DCM. Streptozotocin‐induced type 1 diabetic rats were untreated or treated with ALP (100 mg/kg/d) for 4 weeks and terminated after heart function measurements by echocardiography and pressure‐volume conductance system. Cardiomyocyte H9C2 cells infected with Nrf2 siRNA or not were incubated with high glucose (HG, 25 mmol/L) concomitantly with ALP treatment. Cell viability, lactate dehydrogenase, 15‐F2t‐Isoprostane and superoxide dismutase (SOD) were measured with colorimetric enzyme‐linked immunosorbent assays. ROS, apoptosis, was assessed by dihydroethidium staining and TUNEL, respectively. The Western blot and qRT‐PCR were used to assess protein and mRNA variations. Diabetic rats showed significant reductions in heart rate (HR), left ventricular eject fraction (LVEF), stroke work (SW) and cardiac output (CO), left ventricular end‐systolic volume (LVVs) as compared to non‐diabetic control and ALP improved or normalized HR, LVEF, SW, CO and LVVs in diabetic rats (all P < .05). Hearts of diabetic rats displayed excessive oxidative stress manifested as increased levels of 15‐F2t‐Isoprostane and superoxide anion production, increased apoptotic cell death and cardiomyocytes autophagy that were concomitant with reduced expressions of Nrf2, heme oxygenase‐1 (HO‐1) and Keap1. ALP reverted all the above‐mentioned diabetes‐induced biochemical changes except that it did not affect the levels of Keap1. In vitro, ALP increased Nrf2 and reduced the hyperglycaemia‐induced increases of H9C2 cardiomyocyte hypertrophy, oxidative stress, apoptosis and autophagy, and enhanced cellular viability. Nrf2 gene silence cancelled these protective effects of ALP in H9C2 cells. Activation of Nrf2 subsequent to the suppression of Keap1 and the mitigation of autophagy over‐activation may represent major mechanisms whereby ALP attenuates DCM. 相似文献
28.
Chunhong Xi Yingduan Zhang Mei Yan Qing Lv Huan Lu Jun Zhou Yucheng Wang Jianbo Li 《Journal of cellular and molecular medicine》2020,24(17):10166-10176
Pathogenesis and treatment for diabetic neuropathy are still complex. A deficit of neurotrophic factors affecting Schwann cells is a very important cause of diabetic neuropathy. Neuritin is a newly discovered potential neurotrophic factor. In this study, we explored the effect of exogenous neuritin on survivability and functions of diabetic Schwann cells of rats with experimental diabetic neuropathy. Diabetic neuropathy was induced in rats. 12‐week diabetic rats contrasted with non‐diabetic normal rats had decreased levels of serum neuritin and slowed nerve conduction velocities (NCVs). Schwann cells isolated from these diabetic rats and cultured in high glucose showed reduced cell neuritin mRNA and protein and supernatant neuritin protein, increased apoptosis rates, increased caspase‐3 activities and progressively reduced viability. In contrast, exogenous neuritin treatment reduced apoptosis and improved viability, with elevated Bcl‐2 levels (not Bax) and decreased caspase‐3 activities. Co‐cultured with diabetic Schwann cells pre‐treated with exogenous neuritin in high glucose media, and diabetic DRG neurons showed lessened decreased neurite outgrowth and supernatant NGF concentration occurring in co‐culture of diabetic cells. Exogenous neuritin treatment ameliorated survivability and functions of diabetic Schwann cells of rats with diabetic neuropathy. Our study may provide a new mechanism and potential treatment for diabetic neuropathy. 相似文献
29.
Shan-Shan Su Bao-Peng Li Chun-Lin Li Fang-Rui Xiu Dong-Yan Wang 《Bioscience, biotechnology, and biochemistry》2020,84(6):1123-1130
ABSTRACTThe purpose of this study was to explore the functional implication of microRNA-218 (miR-218) in diabetic nephropathy (DN) through high-glucose-stimulated renal proximal tubule impairment. Biological function experiments showed that miR-218 and inflammatory factors TNF-α and IL-1β were highly expressed in renal proximal tubule under high-glucose conditions. Inhibiting miR-218 alleviated renal tubular cell injury, which was represented by miR-218 inhibitor facilitating renal tubular cell vitality whilst reducing its apoptosis and levels of inflammation factors. In addition, we confirmed that miR-218 directly targeted GPRC5A and negatively regulated its expression. Co-transfection assay showed that overexpression of GPRC5A accentuated the mitigated action of miR-218 inhibitor on renal proximal tubule cell injury induced by high-glucose. Accordingly, these data indicated that downregulation of miR-218 can assuage high-glucose-resulted renal tubular cell damage, and its ameliorative effect was achieved by negative regulation of GPRC5A, which provides a novel direction for unearthing the pathogenesis and even further biological treatment of DN. 相似文献
30.